Deutsche Bank’s Praxis Precision Medicines PRAX Stock Holding History
Bought
Maintained
Sold
Other funds holding PRAX
SAM
Deutsche Bank's PRAX Position: Q2 2026 in Review
Deutsche Bank increased its Praxis Precision Medicines (PRAX) stake by 11% in Q2 2026, buying an estimated $2.05M and bringing the position to 64,263 shares worth $21.5M. The position accounts for 0.01% of the portfolio, ranked #838.
Deutsche Bank first reported a position in PRAX in Q4 2020 and has held it in 23 quarters since. 86 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.
- Deutsche Bank held 64,263 shares of Praxis Precision Medicines worth $21.5M as of Q2 2026.
- Deutsche Bank bought 6,484 Praxis Precision Medicines shares in Q2 2026, an estimated $2.05M.
- Praxis Precision Medicines made up 0.01% of Deutsche Bank's portfolio in Q2 2026, its #838 holding.
- Deutsche Bank first reported a position in Praxis Precision Medicines in Q4 2020 and has held it in 23 quarters since.
- 86 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.
Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.